First Quadrant’s AngioDynamics ANGO Stock Holding History

First Quadrant’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,179	Closed	-$93K	–	621
2020 Q2	$93K	Buy	+9,179	New	+$94.6K	0.01%	565
2019 Q4	–	Sell	-5,317	Closed	-$98K	–	570
2019 Q3	$98K	Hold	5,317	–	–	0.01%	486
2019 Q2	$105K	Hold	5,317	–	–	0.01%	584
2019 Q1	$122K	Sell	5,317 -7,633	-59%	-$166K	0.01%	561
2018 Q4	$261K	Buy	12,950 +7,633	+144%	+$158K	0.02%	483
2018 Q3	$116K	Hold	5,317	–	–	﹤0.01%	696
2018 Q2	$118K	Hold	5,317	–	–	﹤0.01%	635
2018 Q1	$92K	Sell	5,317 -27,342	-84%	-$456K	﹤0.01%	698
2017 Q4	$543K	Sell	32,659 -22,500	-41%	-$384K	0.01%	527
2017 Q3	$943K	Sell	55,159 -57,304	-51%	-$963K	0.02%	442
2017 Q2	$1.82M	Buy	112,463 +6,312	+6%	+$99.8K	0.04%	357
2017 Q1	$1.84M	Hold	106,151	–	–	0.04%	373
2016 Q4	$1.79M	Sell	106,151 -18,084	-15%	-$302K	0.04%	366
2016 Q3	$2.18M	Buy	124,235 +115,535	+1,328%	+$1.87M	0.05%	321
2016 Q2	$125K	Hold	8,700	–	–	﹤0.01%	632
2016 Q1	$107K	Buy	+8,700	New	+$96.1K	﹤0.01%	638

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

First Quadrant's ANGO Position: Q3 2020 in Review

First Quadrant sold out of AngioDynamics (ANGO) in Q3 2020, closing a stake of 9,179 shares — an estimated $93K sold.

First Quadrant first reported a position in ANGO in Q1 2016 and held it in 16 quarters. The position peaked at $2.18M in Q3 2016. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2020.

First Quadrant reported no remaining AngioDynamics position as of Q3 2020 after selling out during the quarter.
First Quadrant sold 9,179 AngioDynamics shares in Q3 2020, an estimated $93K.
First Quadrant first reported a position in AngioDynamics in Q1 2016 and held it in 16 quarters.
First Quadrant's AngioDynamics position peaked at $2.18M in Q3 2016.
138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2020.

Based on First Quadrant's 13F filing for Q3 2020, filed 28 Oct 2020.